TY  -  
T1  - Adrenocortical carcinoma : presentation and outcome of a contemporary patient series 
SN  -  /  
UR  - http://hdl.handle.net/10138/305334 
T3  -  
A1  - Kostiainen, Iiro; Hakaste, Liisa; Kejo, Pekka; Parviainen, Helka; Laine, Tiina; Löyttyniemi, Eliisa; Pennanen, Mirkka; Arola, Johanna; Haglund, Caj; Heiskanen, Ilkka; Schalin-Jäntti, Camilla 
A2  -  
PB  -  
Y1  - 2019 
LA  - eng 
AB  - BackgroundAdrenocortical carcinoma (ACC) is a rare endocrine carcinoma with poor 5-year survival rates of20 Hounsfield Units (HU) for all tumours (median 34 (21-45)), median size 92mm (20-196), Ki67 17% (1-40%), Weiss score 7 (4-9) and Helsinki score 24 (4-48). ACC was more often found in the left than the right adrenal (p5 to>10 years was achieved after repeated surgery of metastases. Overall 5-year survival was 67%, and 96% vs. 26% for ENSAT stage I-II vs. III-IV (p20 on nonenhanced CT but var... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Adrenocortical carcinoma; ENSAT stage; Hounsfield units; Mitotane; Surgery; Complications; Survival; EUROPEAN NETWORK; PROGNOSTIC ROLE; MANAGEMENT; SURVIVAL; CLASSIFICATION; COLLABORATION; ADRENALECTOMY; SOCIETY; DISEASE; ACC; 3122 Cancers; 3126 Surgery, anesthesiology, intensive care, radiology 
N1  -   
PP  -  
ER  -